Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 923-932

  Steger, K K ^c   Valentine, P J ^a   Heffron, F ^a   So, M ^a   Pauza, C D ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; PROTEIN P27;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; STOMACH INTUBATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL VACCINES; EPITOPES; FEMALE; GENE PRODUCTS, GAG; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MALE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0033605375     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00278-3     Document Type: Article

References (31)

1. Doggett T.A., Curtiss R.C. 3rd. Delivery of antigens by recombinant avirulent Salmonella strains. Advances in Experimental Medicine & Biology. 327:1992;73-165.
2. Dougan G., Smith L., Heffron F. Live bacterial vaccines and their application as carriers for foreign antigens. Adv. Vet. Sci. and Comp. Med. 39:1989;271-300.
3. Curtiss I.I.I. R., Kelly S.M., Gulig P.A., Nakayama K. Selective delivery of antigens by recombinant bacteria. Curr. Topics Microbiol. Immunol. 146:1989;35-49.
4. Buchmeier N.A., Heffron F. Induction of Salmonella stress proteins upon infection of macrophages. Science. 248:1990;730-732.
5. Brett S.J., Rhodes J., Liew F.Y., Tite J.P. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA-Salmonella typhimurium with that of live virus. J. Immunol. 150:1993;2869-2884.
6. Valentine P.J., Meyer K.K., Rivera M.M., Lipps C., Pauza C.D., Maziarz R.T., So M., Heffron F. Induction of SIV capsid-specific CTL and mucosal slgA in mice immunized with a recombinant S. typhimurium aroA mutant. Vaccine. 14:1996;138-146.
7. Sadoff J.C., Ballou W.R., Baron L.S., Majarian W.R., Brey R.N., Hockmeyer W.T., Young J.F., Cryz S.J., Ou J., Lowell G.H., Chulay J.D. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science. 240:1988;336-337.
8. Strugnell R., Dougan G., Chatfield S., Charles I., Fairweather N., Tite J., Li J.L., Beesley J., Roberts M. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:1992;3994-4002.
9. + cytotoxic T cells. J. Exp. Med. 172:1990;1083-1090.
10. Turner S.J., Carbone F.R., Strugnell R.A. Salmonella typhimurium ΔaroA ΔaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 61:1993;5374-5380.
11. Dunne M., Al-Ramadi B.K., Barthold S.W., Flavell R.A., Fikrig E. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine lyme borreliosis. Infect. Immun. 63:1995;1611-1614.
12. Redman T.K., Harmon C.C., Lallone R.L., Michalek S.M. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats. Infect. Immun. 63:1995;2004-2011.
13. Zhang T., Stanley S.L. Jr. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect. Immun. 64:1996;1526-1531.
14. Lehner T., Brookes R., Panagiotidi C., Tao L., Klavinskis L.S., Walker J., Walker P., Ward R., Hussain L., Gearing A.J.H., Adams S.E., Bergmeier L.A. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc. Natl. Acad. Sci. 90:1993;8638-8642.
15. Allen T.M., Sidney J., del Guercio M-F., Lehman E., Glickman R.L., Lensmeyer G.L., Wiebe D.A., Pauza C.D., Johnson R.P., Sette A., Watkins D.I. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV. J. Immunol. 160:1998;6062-6071.
16. Almond N., Page M., Mills K., Jenkins A., Ling C., Thorpe R., Kitchin P. The production and purification of PCR-derived recombinant simian immunodeficiency virus p27 gag protein; its use in detecting serological and T-cell responses in macaques. J. Virol. Methods. 28:1990;321-326.
17. smm PFj14. Virology. 219:1997;140-149.
18. Jehuda-Cohen T., Powell J.D., Villinger F., Mayne A.E., Sell K.W., Ansari A.A. Evidence for simian immunodeficiency virus-specific IgM and IgG response in peripheral blood mononuclear cells of serum enzyme-linked immunosorbent assay-negative nonhuman primates. Journal of Acquired Immune Deficiency Syndromes. 7:1994;505-539.
19. Miller M.D., Lord C.I., Stallard V., Mazzara G.P., Letvin N.L. Gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. J. Immunol. 144:1990;122.
20. Yasutomi Y., Koenig S., Haun S.S., Stover C.K., Jackson R.K., Conard P., Conley A.J., Emini E.A., Fuerst T.R., Letvin N.L. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150:1993;3101-3107.
21. Nardelli-Haefliger D., Roden R.B.S., Benyacoub J., Sahli R., Kraehenbuhl J-P., Schiller J.T., Lachat P., Potts A., De Grandi P. Human Papillomavirus Type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:1997;3328-3336.
22. Tacket C.O., Kelly S.M., Schödel F., Losonsky G., Nataro J.P., Edelman R., Levine M.M., Curtiss I.I.I. R. Safety and immunogencity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded Hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun. 65:1997;3381-3385.
23. Franchini G., Robert-Guroff M., Tartaglia J., Aggarwal A., Abimiku A., Benson J., Markham P., Limbach K., Hurteau G., Fullen J., et al. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques. AIDS Research & Human Retroviruses. 11:1995;909-920.
24. Steger K.K., Pauza C.D. Immunization of Macaca mulatta with aroA-attenuated Salmonella typhimurium expressing the SIVp27 antigen. J. Med. Primatol. 26:1997;44-50.
25. Bienenstock J., Befus D., McDermott M., Mirski S., Rosenthal K. Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA. Federation Proc. 42:1983;3213-3217.
26. Guy-Grand D., Griscelli C., Vassalli P. The mouse gut T lymphocyte, a novel Type of T cell; nature, origin and traffic in mice in normal and graft-versus-host conditions. J. Exp. Med. 148:1978;1661-1677.
27. Husband A.J., Gowans J.L. The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J. Exp. Med. 148:1978;1146-1160.
28. Thomas H.C., Parrott M.V. The induction of tolerance to a soluble protein antigen by oral administration. Immunology. 27:1974;631-639.
29. Thomasi T.J. Oral tolerance. Transplantation. 29:1980;353-356.
30. Al-Ramadi B., Brodkin M., Mosser D., Eisenstein T. Immunosuppression in by attenuated Salmonella: Evidence for mediation by macrophage precursors. J. Immunol. 146:1991;2737-2746.
31. Al-Ramadi B., Chen Y-W., Meissler J., Eisenstein T. Immunosuppression induced by attenuated Salmonella: Reversal by IL-4. J. Immunol. 147:1991;1954-1961.